BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Microbiome Times Magazine - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.microbiometimes.com
X-WR-CALDESC:Events for Microbiome Times Magazine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Athens
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190128
DTEND;VALUE=DATE:20190131
DTSTAMP:20260423T074500
CREATED:20181124T120245Z
LAST-MODIFIED:20181201T154359Z
UID:1914-1548633600-1548892799@www.microbiometimes.com
SUMMARY:The Microbiome Movement - Drug Development Europe
DESCRIPTION:Pursuing Disease Causation To Foster The Creation Of Microbiome-Based Therapeutics & Diagnostics \nRecent breakthroughs in DNA sequencing\, metagenomic analysis and computational techniques have given scientists new insight into the structure and function of the human microbiota\, an interconnected community of symbiotic\, commensal and pathogenic microorganisms. As valuable clinical data solidifies the importance of the human microbiome on human health and disease\, recent efforts have sought to harness this research to create microbiome-based therapeutics. \nSituated at the heart of therapeutic R&D\, the Microbiome Movement – Drug Development Summit kick starts 2019\, once again to help large pharma\, biotech and academic institutions accelerate the discovery\, clinical development of safe\, effective and commercially scalable microbiome therapeutics across a broad range of disease indications. \nSet to tackle the greatest scientific\, regulatory\, clinical\, manufacturing and commercialisation challenges across the entire drug development value chain\, this meeting will showcase leading industry case studies focused on enhancing the application of novel technologies to standardise results\, accelerate target discovery and optimise the translation of microbiome research into safe and effective therapeutic products. \nTo see the full agenda\, speaker list\, networking opportunities and more\, visit the website.
URL:https://www.microbiometimes.com/event/the-microbiome-movement-drug-development-europe/
LOCATION:Novotel Paris East\, 1 Avenue de la Republique\, Paris\, 93177\, France
ATTACH;FMTTYPE=image/jpeg:https://www.microbiometimes.com/wp-content/uploads/2018/11/MM_DRUG-DEVELOPMENT-EUROPE-00000002.jpg
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR